Saphtx develops protein-based therapeutic strategies for a wide range of diseases.
Saphtx develops protein-based therapeutic strategies for a wide range of diseases. The company was founded in 2018 and is headquartered in Newark, New Jersey.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 17, 2020 | Grant | $255.93K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |